Xencor (XNCR) Competitor Comparison
We are evaluating the key criteria listed to compare Xencor (XNCR) against its competitors in the Biotechnology industry.
Market Capitalization
95 / 368Gross Profits
184 / 278Total Revenue
76 / 300EBITDA
237 / 337Free Cashflow
275 / 352Quick Ratio
75 / 357Earnings per Share
265 / 359Dividend yield
0 / 6Total Cash
61 / 358Performance 3 years
148 / 368Performance 5 years
155 / 368Performance 10 years
57 / 368Linearity 3 years
68 / 368Linearity 5 years
71 / 368Linearity 10 years
100 / 368Total Rank
70 / 368Dividend Rank
314 / 368Valuation Rank
247 / 368Piotroski Rank
184 / 368Muliplier Rank
240 / 368Performance 3 years - XNCR ranking 148 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.